NRC HealthNRC
Recorded

NRC Health 2026 Q2 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ2 2026Duration43 minParticipants8

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Hello, everyone. Thank you for joining us, and welcome to the NRC Q2 2026 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one to raise your hand. To withdraw your question, press star one again. I will now hand the conference over to Jordan Freeman, NRC Health's Chief Accounting Officer. Jordan, please go ahead. Thank you, operator.

Jordan FreemanChief Accounting Officer

Welcome to NRC Health's earnings conference call for the second quarter ended June 30th, 2026. I wanted to first let you know that we posted our earnings press release to the investor relations section on our website. On this call today, we have NRC Health CEO, Trent Green, and CFO, Shane Harrison. Today's call will include statements related to the expected future results of our company, which are therefore forward-looking statements. Actual results may differ materially from these expectations due to a number of risks and uncertainties, including those described in our earnings release and other SEC filings. We will also reference non-GAAP financial measures. Definitions and reconciliations to the most comparable GAAP measures are provided in our earnings press release, which is available on our investor relations website. A replay of this call will also be posted to the same website.

Jordan FreemanChief Accounting Officer

With that, let me turn our call over to our CEO, Trent Green.

Trent GreenCEO

Thank you, Jordan. Good afternoon, everyone. Thank you for joining us for NRC Health's second quarter 2026 earnings call. Today, I'll begin with an overview of our second quarter performance, discuss the momentum we're seeing across the business, and highlight how we continue to advance the next chapter of the NRC Health story with innovation across our product portfolio. We delivered another strong quarter of execution in the second quarter, reflected in our year-over-year Total Recurring Contract Value, or TRCV, and revenue growth. During the quarter, TRCV increased 11% year-over-year, with diversified growth across the business. Experience TRCV grew in the mid-teens compared to the prior year, driven by strong bookings activity during the first half of this year. Also notable in the quarter was The Governance Institute, which achieved its strongest bookings performance in seven years and grew its TRCV by nearly 10% year-over-year.

Trent GreenCEO

This performance reinforces our conviction that healthcare leaders increasingly value trusted strategic guidance alongside technology-enabled solutions. Our TRCV growth reflects more than market demand. It demonstrates the effectiveness of our strategy. The sales organization we redesigned around buyers continues to perform well, enabling deeper engagement across Experience, Market Insights, and The Governance Institute. By aligning with how health systems make decisions, we're creating larger, more strategic relationships and expanding our opportunity to deliver value across the enterprise. We're also seeing encouraging returns from our continued product investments, particularly those that connect experience measurement with experience improvement. Those capabilities were a key differentiator in the landmark multi-solution agreement we discussed last quarter and continue to resonate with healthcare organizations looking for partners who can move beyond insight to measurable action. Turning to our financial performance, second quarter revenue increased approximately 4% year-over-year and 2% sequentially.

Trent GreenCEO

Despite an approximately 2-point headwind from an accounting change related to certain reputation monitoring solutions, which Shane will discuss in greater detail. Adjusted EBITDA margin was 27%, consistent with the first quarter, as we continued investing ahead of revenue and implementation, customer success, and product development to support our large first quarter win and a growing pipeline of opportunities. This performance is consistent with expectations we outlined last quarter. As planned, we maintain margins while building the delivery capacity required for the first phase of this multi-year engagement. We continue to expect margin expansion in the second half of the year as revenue increasingly reflects the TRCV growth we've generated. More broadly, our investment philosophy remains unchanged. We're investing deliberately in the capabilities that strengthen long-term customer relationships, accelerate product innovation, and expand our competitive advantage.

Trent GreenCEO

We believe these investments position NRC Health to deliver durable growth and attractive incremental margins as these programs mature and scale. Product innovation remains one of our highest strategic priorities. During the quarter, we continued to strengthen our solution families. Beginning with The Governance Institute, we've expanded our capabilities by engaging in a refresh of our board assessment tools, increasing our benchmarking capabilities, and developing board effectiveness resources that help healthcare boards and executive teams govern more strategically. We believe governance is becoming an increasingly important differentiator as health systems navigate unprecedented financial, workforce, and regulatory complexity. We're investing to ensure The Governance Institute remains the trusted partner for healthcare leadership. Within the Experience family, we're particularly excited about the recent launch of ambient listening with agentic AI in our rounding solution.

Trent GreenCEO

Rather than having frontline leaders use clipboards and static question sets to engage with patients and document those conversations, our ambient listening feature allows them to remain fully present while AI securely captures the interaction in the background, saving them transcribing time, automatically organizing conversations into meaningful summaries, identifying themes, surfacing service recovery opportunities, and preparing documentation for review. Early deployments have demonstrated dramatically richer documentation and insights without increasing the time leaders spend rounding, a meaningful step forward in helping healthcare organizations move from measuring experience after the fact to improving it in real time. Perhaps the most exciting opportunity extends well beyond any single product release. Over more than four decades, NRC Health has been solely focused on healthcare and has built both deep client relationships and one of healthcare's richest and most interconnected experience data sets.

Trent GreenCEO

We uniquely connect what consumers expect before they choose care, what patients experience throughout their care journey, and how employees help shape those experiences from within the organization. No other organization can offer our laser focus and this breadth, depth, and longitudinal history of healthcare experience data. That foundation creates a significant competitive advantage as AI continues to reshape our industry. Our objective is not simply to apply AI to healthcare, it's to apply AI to one of healthcare's most differentiated data sets. By mining decades of interconnected patient, consumer, employee, and market data, we can identify patterns, uncover drivers of loyalty and experience, predict opportunities for improvement, and recommend actions with a level of context a generic AI model simply cannot provide. All of which can drive a virtuous cycle of higher consumer attraction, better patient outcomes, improved caregiver careers, and higher customer return on investment.

Trent GreenCEO

In our view, this is the next evolution of human understanding. We aren't simply helping healthcare organizations understand what happened. We're helping them understand why it happened, what's most likely to happen next, and what actions will create the greatest impact for patients, communities, and caregivers they serve. Stepping back, our strategy continues to be grounded in three elements: insight, engagement, and enablement. Insight provides a continuous view into what patients, families, employees, and communities expect and experience throughout their healthcare journey. Engagement aligns leaders and teams around what needs to change, supported by our customer success teams, partnerships like the one we recently announced with the Healthcare Experience Foundation, and platforms like The Governance Institute. Enablement is where improvement happens through tools, workflows, and practices that convert insight into better performance, which may be measured in improved patient and employee experience, stronger volumes, and lower costs.

Trent GreenCEO

We believe we are increasingly differentiating ourselves in this industry, particularly in those engagement and enablement layers. Many players can generate data and dashboards, but fewer can help a health system act on what the data is telling them, especially when those answers are nuanced or financially meaningful. Our opportunity is to combine healthcare-specific intelligence, governance expertise, and enablement tools to drive real behavior change across the thousands of care sites we serve. I'm proud of how our teams executed in the quarter, driving double-digit year-over-year TRCV growth, sustaining revenue momentum, advancing The Governance Institute offering, and investing with discipline in delivery and product. The foundation is solid, our opportunity ahead is clear, and the healthcare industry's need for what NRC Health delivers, turning human understanding into meaningful, measurable action, has never been greater.

Trent GreenCEO

With that, I'll turn it over to Shane to walk through our second quarter financial results.

Shane HarrisonCFO

Thank you, Trent, and good afternoon, everyone. I'll take the next few minutes to walk through our Q2 2026 results, provide context on our profitability dynamics as we invest to support our TRCV growth, and give an update on capital allocation, including our dividend and share repurchase activity. Starting with TRCV, we finished the quarter with Total Recurring Contract Value of $151.9 million, up 11% year-over-year, reflecting continued strength across our Experience, Market Insights, and The Governance Institute portfolios. Q2 revenue was up approximately 4% year-over-year and 2% sequentially. This included a roughly two-point growth headwind related to a change in revenue recognition for several of our reputation management SKUs. This was due to the strategic replacement of a third-party vendor for some elements of these solutions, where the new arrangement requires net revenue accounting, which means the vendor's fees are offset as contra revenue rather than expense.

Shane HarrisonCFO

Previous accounting was traditional gross revenue and expense recognition. This accounting change had a pronounced revenue impact in the second quarter, we expect to see a smaller headwind in Q3 and Q4. The relationship between TRCV and revenue recognition remains consistent with what we've described previously. TRCV growth leads revenue as implementations ramp, especially for larger multi-site customers like the landmark win we discussed last quarter, which will begin to show revenue during Q3. We continue to expect that the strong TRCV performance we've posted over the past several quarters will support durable revenue growth as implementations mature. Moving to profitability. Second quarter Adjusted EBITDA was $9.4 million, with a margin of 27%, which was essentially flat with Q1, in line with our expectation that margins would remain steady this quarter while we invest in delivery and customer success for our large new implementations.

Shane HarrisonCFO

Year-over-year, EBITDA was three points, or $900,000 lower, primarily driven by higher operating expenses tied to expansion in our delivery teams, ongoing product and platform investments, and the normalization of certain corporate expenses following the executive team build-out we completed in 2025. These investments are intentional and aligned with our long-term growth strategy, we expect margin improvement as revenue catches up to the TRCV we've already secured. For modeling purposes, we expect third quarter revenue to increase sequentially and Adjusted EBITDA margin to be approximately the same as the first half of the year, due primarily to the timing of our annual customer conference occurring in September. In the fourth quarter, we expect to see upside to our EBITDA margin as we scale revenue and see our operating expenses normalize from Q3.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day